Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Abatacept in Acute Myeloid Leukemia: NCT07238712 Clinical Landscape Report 2026
15 October 2026
NCT07238712 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MIT-004 in Multiple Sclerosis: CTRI/2025/11/097877 Clinical Landscape Report 2026
15 October 2026
CTRI/2025/11/097877 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Alendronate Sodium in Fractures, Bone: NCT07245381 Clinical Landscape Report 2026
15 October 2026
NCT07245381 clinical landscape for Fractures, Bone: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cisplatin in Locally Advanced Cervical Carcinoma: NCT07244965 Clinical Landscape Report 2026
15 October 2026
NCT07244965 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07244367 Clinical Landscape Report 2026
15 October 2026
NCT07244367 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ixekizumab in Psoriasis vulgaris: CTRI/2025/11/097895 Clinical Landscape Report 2026
15 October 2026
CTRI/2025/11/097895 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CAR19-BCMA dual-target CAR-T(Hebei Taihe Chunyu Biotechnology) in Multiple Myeloma: NCT07249073 Clinical Landscape Report 2026
15 October 2026
NCT07249073 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT07247097 Clinical Landscape Report 2026
15 October 2026
NCT07247097 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BRL-305 in Relapse multiple myeloma: NCT07248176 Clinical Landscape Report 2026
15 October 2026
NCT07248176 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus: NCT07251556 Clinical Landscape Report 2026
15 October 2026
NCT07251556 clinical landscape for Diabetes Mellitus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zasocitinib in Plaque psoriasis: NCT07250802 Clinical Landscape Report 2026
15 October 2026
NCT07250802 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Soficitinib in Plaque psoriasis: NCT07251998 Clinical Landscape Report 2026
15 October 2026
NCT07251998 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.